How much does targeted therapy cost a month and how much does targeted therapy cost

Targeting is a way to target the identified carcinogenic sites at the cellular molecular level, which means that the drug can be injected into the body to specifically select the tumor site and inject it, without harming the normal tissues around the tumor! The cost of targeting ** is relatively high, you had better go to the hospital where you need ** to consult, everyone's situation is different, and the charging standards are different

It has to do with a lot of factors.

Regional. There is also physical condition.

There are also options for medications.

If you target, you can do it.

Each course of treatment is 10,000, about 6-8 courses. There will also be regional differences, doing more activities can help your own cell resistance, and by speeding up the pace of exercise activities, the source of nutrition for cancer cells can also be well reduced.

Also, eat plenty of highly alkaline foods and drink plenty of water. This is the best scenario.

How much does it cost to target** a month.

Each course of treatment is 10,000, about 6-8 courses. There will also be regional differences, targeting in foreign countries** is cheaper than in China, and Huijia Medical can match foreign targeting, professional, you can search and see.

For cancer cells, many programs are targeted, and many patients have been relieved to a certain extent after taking targeting, so the cost of targeting has become a problem that everyone is very concerned about, and I will introduce it to you below.

1.Targeting**A course of treatment is about 30,000 judgments, although targeting** is more targeted for cancer killing, and there are fewer targets for normal cells and tissues, but not all patients are suitable for targeting**, and only patients with positive EGFR are applicable.

2.Moreover, the scope of targeting ** is limited, and **incompletely leads to kidney cancer**, which not only endangers the health of patients but also increases the economic burden. And the *** of targeted drugs will also reduce the ** effect.

3.Biological multicellular immunity breaks the disadvantages of targeting and is not well modified, large and incomplete, and provides a new model for kidney cancer patients, and combined targeting can also exert greater efficacy.

Precautions. During the targeting** period, it is necessary to pay attention to some symptoms such as rash, respiratory function and diarrhea, including some changes in liver function.

It's expensive, but why are targeted drugs so expensive? Is it really that the pharmaceutical factory is too dark? Aren't the ingredients of these drugs very simple, and the raw materials are very cheap, why do you need thousands of dollars a bottle to put in a package?

I'm not going to speak for the pharmaceutical company here, but I'm going to tell you the story.

A drug was developed in the past and today.

One of the most common things that happens in pharmaceutical companies is that they find 10,000 compounds that can kill cancer cells, and then they want to make them into pills.

Then it was found that only 500 of the 10,000 drugs were made into pills, and eating them to mice could inhibit cancer cells in the mice and not make the mice die.

After giving it to people, it was found that only 200 would not cause serious adverse reactions, and then several rounds of clinical trials began, each round of clinical trials had to start a large number of scientific researchers, medical personnel cooperated, and the publication of articles, and finally only 10 drugs may be proven to be effective, this process often takes 5-10 years, and finally only 2-3 drugs of the real 10 drugs may be on the market.

However, after the market, there may be 1-2 drugs that will be withdrawn from the market due to serious adverse reactions, so it may take 10-15 years for these 10,000 compounds to finally become drugs that we can use. Everything else is a waste of time, at least money and time spent trying out what is wrong.

Only a small percentage of people pay the bill.

The research and development of targeting** and immune** even the medical economy in the United States has a tendency to be dragged down, because its R&D cost and cycle are too high, and the drugs developed by hundreds of millions may not survive to the market, which greatly increases the cost and selling price of drugs. And more importantly, in order to mutate the probability of only a few hundred people in the world can buy drugs, but these hundreds of millions of research and development costs cannot be saved, so in the end it can only increase the burden on this small number of patients.

However, folk remedies are completely unnecessary, many drugs in my country, as long as there is a reasonable formula, can directly produce drugs for sale, these drugs I do not recommend friends to try. Because many times these drugs are not too big, but the main reason is not because they have a good formula and strong effect, but because they don't have much effect, just a bottle of sugar water.

There are many people who say that there are hundreds of Chinese herbs added to it, in fact, you can understand it this way, often the result of these drug tests is that all the drugs in it may not add up, and they can't close the dose of a bowl of normal Chinese medicine, just like if you beat an egg in the upper reaches of the Yangtze River, it is said that all the people in the lower reaches of the Yangtze River have drunk egg drop soup.

Targeting** is effective for both early- and late-stage cancer patients, not all cancer patients are suitable for targeting**, and only one-third of cancer patients are suitable for targeting**.

This one-third of people have patients with genetic mutations that have mutated certain genes in their bodies.

Because targeted drugs are only effective for tumor patients with related radical mutations, cancer patients without gene mutations who are not suitable for chemotherapy with targeted drugs are still their preferred drugs.

Targeting ** also has shortcomings, its effect is not 100%, and drug resistance will occur over time, which means that the tumor in the body of the tumor patient is not sensitive to targeted drugs, and the effect will get worse and worse, and even no effect in the end.

Moreover, the ** of targeted drugs is very expensive, which is difficult for ordinary families to afford, and the ** targeted drug is not the most perfect way.

During the ** period, you should also pay more attention to improving immunity, take good rest to ensure sufficient sleep time, pay attention not to eat greasy and spicy food, and eat more light and easily digestible food.

Expensive, just know about it.

The average cost of developing a new drug is about $100 million, including $1.4 billion in R&D expenses and $100 million in investment losses over the same period, not counting the average $100 million after-sales expenses per drug.

Why can't these pharmaceutical companies make small profits but sell quickly? Because most of the targeted drugs are used by patients with advanced cancer, the survival period of these patients is relatively short, and they must change drugs if they have drug resistance (which is why many drugs can be free after taking 150,000 or how much money, because many people can't hold on for a long time after being free at all, or drug resistance), so the total number of drug buyers is always on a more appropriate basis (the number of people is not too much, so "multi-sales" cannot exist). Taking inflation and the research and development of alternative drugs into account, the price of a new imported drug must have been carefully calculated to ensure the maximum profitability of the pharmaceutical company.

From a pharmacological point of view, targeted drugs are new dosage forms that can be specially researched and developed in recent years with the help of carriers, ligands or antibodies, which can selectively reach target tissues, target organs, and target cells at specific sites. Especially in cancer, compared with other drug dosage forms, it has incomparable superiority, which can minimize the impact of anti-cancer drugs on the body's normal tissues and organs.

It is normal to be expensive, the cycle of new drug research and development is long, the investment is high, the risk is high, the targeted preparation is very high-tech, and it involves the protection of imported patents and other reasons, which is naturally high. But there is no doubt about the efficacy of targeted drugs.

The drugs used in targeted drugs are basically some cancers, and the names of specific drugs are different, especially when the cancer is in the advanced stage, some targeted drugs will need to be used, so the targeted drugs in the advanced stage of cancer are particularly expensive, because the targeted drugs are mainly smaller, so they can effectively inhibit the spread of some malignant tumors and cancer, and they will be more expensive.

Targeting** has greatly improved the survival time of lung cancer patients, especially those with advanced lung cancer. These drugs made in the country are significantly cheaper than those in foreign countries, and many targeted drugs have entered the medical insurance. Therefore, although targeted drugs** are very expensive, most people can still accept them after medical insurance reimbursement.

However, there are some drugs that are indeed more expensive. However, not all lung cancers are suitable for targeting**, and only patients with certain sensitive gene mutations are suitable for targeting**. In the early days of targeted drugs, they were very expensive, but with the decline in cost, some generic drugs in China appeared, and targeted drugs for lung cancer, including gefitinib, erlotinib, osimertinib, etc., have been localized.

Because when you encounter, because when you encounter cancer, money is not money, it is paper.

Targeted drugs are quite expensive, a box of drugs is basically tens of thousands or even tens of thousands, and a box can be eaten for a month. You can learn about ginsenoside RG3, which can play a role in controlling the non-deterioration of tumors by inhibiting tumor angiogenesis, cutting off the necessary nutrient channels required for tumor growth at the source of the lesion, and starving the tumor